Clinical Trials Logo
  1. Home
  2. Pseudohypoparathyroidism
  3. NCT00004661

Study of the Regulation of Parathyroid Hormone Secretion in Pseudohypoparathyroidism

Pseudohypoparathyroidism Clinical Trial

Clinical Trial Summary

OBJECTIVES:

Determine the relationship between serum calcium concentrations and parathyroid hormone secretion in patients with pseudohypoparathyroidism.

Clinical Trial Description

PROTOCOL OUTLINE:

Patients are tested for parathyroid hormone response following sequential graded intravenous infusions of sodium citrate and calcium gluconate. Assays include ionized calcium and intact parathyroid hormone. ;

Study Design

Primary Purpose: Screening

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00004661
Study type Observational
Source Office of Rare Diseases (ORD)
Contact
Status Completed
Phase N/A
Start date May 1993
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03029429 - Theophylline Treatment for Pseudohypoparathyroidism Phase 2
Recruiting NCT04969926 - Natural History Study of Parathyroid Disorders
Enrolling by invitation NCT04240821 - Theophylline for Treatment of Pseudohypoparathyroidism Phase 2
Recruiting NCT05945576 - IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Active, not recruiting NCT02551120 - Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
Recruiting NCT04551170 - Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old Phase 2
Completed NCT02411461 - Early-onset Obesity and Cognitive Impairment in Children With Pseudohypoparathyroidism
Completed NCT00001242 - Studies of States With Resistance to Vitamin D and Parathyroid Hormone
Active, not recruiting NCT00497484 - Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia) N/A